Leiner Files For Chapter 11 Protection, Explores Selling Business
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' shutdown of its U.S. OTC operations a year ago forced the firm to seek Chapter 11 bankruptcy protection and explore selling its U.S. business
You may also be interested in...
NBTY Anticipates Nearly 25 Percent Boost From Leiner’s Business
Supplement manufacturer NBTY expects the addition of Leiner Health Products' business will increase its annual sales by more than $500 million - nearly 25 percent
NBTY Receiving Requests To Restart Leiner’s U.S. OTC Business
Vitamin and supplement manufacturer NBTY says it has received requests to restart Leiner Health Products' U.S. private-label OTC business, but deciding whether to make the move will take up to four months
Leiner Teetered Toward Bankruptcy As FDA Investigated Testing Fraud
Whistleblowers' allegations of stability data manipulation at Leiner Health Products prompted the firm's rapid fall from a leading provider of private-label OTC drugs and dietary supplements to a property bought by a competitor in a bankruptcy court auction